PCSA
Processa Pharmaceuticals, Inc. Common
stockNASDAQ
At CloseOct 22, 2026
1.86USD+5.682%(+0.10)16,145
Loading…
Loading…
5.03M
Healthcare
Biotechnology
HQ
Hanover, MD, USA
Previous Close
$1.76
Beta
1.19
52-Week High
$10.84 2025-10-29
52-Week Low
$1.04 2026-10-09
SMA 50
$1.91
SMA 200
$2.41
Avg. Vol 10D
364,440
Avg. Vol 30D
138,952
Avg. Vol 90D
210,466
Relative Vol
0.12
2.79M
2.38M
85.35%
4,140
0.18%
1.00
39%/61%
51.27%
48.23%
11.5000%
200,000
2,140
900
2,140
Nov 5, 2026 (13d)
Dec 17, 2025 · 1-for-25 (reverse)
-13.4M
PCSA Profile
processa pharmaceuticals was founded in october 2017 with a mission to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. the company is headquartered in hanover, maryland.
PCSA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.68 | 2026-10-15 | +7.14% | 0.232 |
| 1M | 1.88 | 2026-09-22 | -4.25% | 2.820 |
| 3M | 2.54 | 2026-07-22 | -29.13% | 2.700 |
| 6M | 3.07 | 2026-04-22 | -41.37% | 2.903 |
| 1Y | 6.96 | 2025-10-22 | -74.12% | 1.194 |
| 2Y | 33.50 | 2024-10-22 | -94.63% | — |
| 5Y | 3,445.00 | 2021-10-22 | -99.95% | 0.487 |
PCSA Stock Summary
Processa Pharmaceuticals, Inc. Common (NASDAQ:PCSA) stock price today is $1.80, and today's volume is 16,145. PCSA is up 2.273% today. The 30 day average volume is 138,952. PCSA market cap is $5.03M with 2.79M shares outstanding.